Drug comparisons
Naratriptan vs Ubrogepant
Compare Naratriptan vs Ubrogepant for migraine relief. Naratriptan is a triptan with CV risks; Ubrogepant is a newer CGRP blocker safer for heart patients.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for acute migraine patients seeking triptan alternatives due to cardiovascular contraindications or inadequate response.
Bottom line
Ubrogepant may suit those with CV risks better than Naratriptan, though individual factors decide the optimal choice.
All medication comparisons